Shigenobu Emoto

Shigenobu Emoto

Auto-generated profile, based on publicly available information

Shigenobu Emoto

Department of Surgical Oncology University of Tokyo Tokyo Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Asian Journal of Surgery
Verified
Journal Article
Open access
SEShigenobu Emoto
Shigenobu Emoto
HNHiroaki Nozawa
Hiroaki Nozawa
KKKazushige Kawai
Kazushige Kawai
KHKEISUKE Hata
KEISUKE Hata
TTToshiaki Tanaka
Toshiaki Tanaka
SISoichiro Ishihara
Soichiro Ishihara
Colorectal surgery is associated with a high risk of perioperative venous thromboembolism (VTE), and this risk is especially high following colorectal cancer resection and surgery for inflammatory bowel disease. Previous analyses of large databases have reported the incidence of postoperative VTE in this population to be approximately 1.1%-2.5%. Therefore, to minimize this risk, patients should be offered appropriate prophylaxis, which may involve a combination of mechanical and pharmacologic prophylaxis with low-dose unfractionated heparin or low molecular weight heparin as recommended by several guidelines. Prior to initiation of treatment, appropriate risk stratification should be performed according to the patients' basic and disease-related as well as procedure-related risk factors, and post-operative factors. Furthermore, a risk-benefit calculation that takes into account patients' VTE and bleeding risk should be performed prior to starting pharmacologic prophylaxis and to help determine the duration of treatment.

2 January 2018 in Anticancer Research
Verified
Journal Article
Open access
PDF file
KMKoji Murono
Koji Murono
KKKazushige Kawai
Kazushige Kawai
KHKEISUKE Hata
KEISUKE Hata
SEShigenobu Emoto
Shigenobu Emoto
MKManabu Kaneko
Manabu Kaneko
HNHiroaki Nozawa
Hiroaki Nozawa
Although systemic chemotherapy has been improved, peritoneal carcinomatosis remains a factor of poor prognosis in patients with colorectal cancer. In order to achieve a higher drug concentration in the peritoneal cavity, intraperitoneal chemotherapy has been performed. However, the optimal regimen for intraperitoneal chemotherapy has not been determined. In this review of intraperitoneal chemotherapy for colorectal cancer, we summarize regimens of hyperthermic intraperitoneal chemotherapy (HIPEC) and other intraperitoneal chemotherapy modalities, such as early postoperative intraperitoneal chemotherapy (EPIC) and sequential postoperative intraperitoneal chemotherapy (SPIC). Mitomycin C and oxaliplatin are the most common chemotherapeutic agents used for HIPEC. Some combination therapies such as those involving bevacizumab, H2O2, and amifostine have potential to increase HIPEC efficacy. 5-Fluorouracil is used mainly for EPIC and SPIC. Some new agents such as paclitaxel, melphalan, and various nanoparticles have been developed. These novel chemotherapeutic agents may achieve clinical implementation in the future.

12 April 2022 in Anz Journal of Surgery
Verified
Journal Article
Closed access
HNHiroaki Nozawa
Hiroaki Nozawa
KOKazuaki Okamoto
Kazuaki Okamoto
KKKazushige Kawai
Kazushige Kawai
KSKazuhito Sasaki
Kazuhito Sasaki
SEShigenobu Emoto
Shigenobu Emoto
SISoichiro Ishihara
Soichiro Ishihara


1 January 2022 in Asian Journal of Surgery
Verified
Journal Article
Open access
KSKazuhito Sasaki
Kazuhito Sasaki
HNHiroaki Nozawa
Hiroaki Nozawa
KKKazushige Kawai
Kazushige Kawai
KMKoji Murono
Koji Murono
SEShigenobu Emoto
Shigenobu Emoto
SISoichiro Ishihara
Soichiro Ishihara
Analysis of long-term clinical outcomes of patients with familial adenomatous polyposis is critical in reducing or preventing the incidence of extracolonic malignancies after initial surgery. The aim of the present study was to clarify the long-term outcomes, and establish a surveillance strategy for surgically treated familial adenomatous polyposis patients. Between January 1967 and March 2020, retrospective data were collected from 37 patients with familial adenomatous polyposis treated or monitored in our department. Occurrence of metachronous cancers, including rectal cancers and extracolonic malignancies, and other diseases was analyzed. The median follow-up duration after the first surgery was 13.8 years. Initially, 16 patients underwent total proctocolectomy with ileal pouch-anal anastomosis, 18 underwent total colectomy with ileorectal anastomosis, and three underwent other procedures. A secondary proctectomy was performed for 9 of the 18 patients who underwent ileorectal anastomosis. Rectal cancer was diagnosed in 6 patients who underwent ileorectal anastomosis. In addition, 5 gastric cancer, 2 duodenal cancer, 1 gallbladder cancer, and 1 thyroid cancer cases were diagnosed. The age at which the extracolonic malignancies were diagnosed was >50 years. 4 patients died due to metachronous rectal cancer, gastric cancer, or gallbladder cancer. Careful consideration should be paid before choosing ileorectal anastomosis as the treatment procedure for familial adenomatous polyposis patients because completion proctectomy was eventually necessary for half of the patients. Long-term surveillance, with more frequent gastric surveillance for patients over 50 years, is important for the prevention and treatment of extracolonic malignancies in familial adenomatous polyposis patients.

31 December 2023 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
YYYuichiro Yokoyama
Yuichiro Yokoyama
HNHiroaki Nozawa
Hiroaki Nozawa
KSKazuhito Sasaki
Kazuhito Sasaki
KMKoji Murono
Koji Murono
SEShigenobu Emoto
Shigenobu Emoto
SISoichiro Ishihara
Soichiro Ishihara
In Western countries, the gold-standard therapeutic strategy for rectal cancer is preoperative chemoradiotherapy (CRT) following total mesorectal excision (TME), without lateral lymph node dissection (LLND). However, preoperative CRT has recently been reported to be insufficient to control lateral lymph node recurrence in cases of enlarged lateral lymph nodes before CRT, and LLND is considered necessary in such cases. We performed a literature review on aspects of pelvic anatomy associated with rectal surgery and LLND, and then combined this information with our experience and knowledge of pelvic anatomy. In this review, drawing upon research using a 3-dimensional anatomical model and actual operative views, we aimed to clarify the essential anatomy for LLND. The LLND procedure was developed in Asian countries and can now be safely performed in terms of functional preservation. Nonetheless, the longer operative time, hemorrhage, and higher complication rates with TME accompanied by LLND than with TME alone indicate that LLND is still a challenging procedure. Laparoscopic or robotic LLND has been shown to be useful and is widely performed; however, without a sufficient understanding of anatomical landmarks, misrecognition of vessels and nerves often occurs. To perform safe and accurate LLND, understanding the landmarks of LLND is essential.